Commission Regulation (EU) 2026/876 of 21 April 2026 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, aclonifen, deltamethrin, oxathiapiprolin and potassium phosphonates in or on certain products